Mantle cell lymphoma and its management: where are we now?-Reference-Cited by-同舟云学术

Mantle cell lymphoma and its management: where are we now?

Published:2019-01-30 Issue:1 Volume:8 Page:
ISSN:2162-3619
Container-title:Experimental Hematology & Oncology
language:en
Short-container-title:Exp Hematol Oncol

Author:

Ladha Abdullah,Zhao Jianzhi,Epner Elliot M.,Pu Jeffrey J.^ORCID

Funder

National Institute on Drug Abuse

Aplastic Anemia and MDS International Foundation

American Cancer Society

Pagie's Cancer Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s40164-019-0126-0.pdf

Reference72 articles.

1. Berard CW, Dorfman RF. Histopathology of malignant lymphomas. Clin Haematol. 1974;3:39–76.

2. Toksdorf G, Stein H, Lennert K. Morphological and immunological definition of a malignant lymphoma derived from germinal centre cells with cleaved nuclei (centrocytes). Br J Cancer. 1980;41(2):168–82.

3. Lennert K, Stein H, Kaiserling E. Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer Suppl. 1975;2:29–43.

4. Weisenburger DD, Kim H, Rappaport H. Mantle-Zone Lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer. 1982;49(7):1429–38.

5. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES. Lymphocytic lymphoma of intermediate differentiation. Morphologica and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol. 1990;14(8):752–63.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spleen-targeted delivery systems and strategies for spleen-related diseases;Journal of Controlled Release;2024-06

2. A Phase I Study using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Elderly Patients with Mantle Cell Lymphoma;2024-03-27

3. Resistance to PRMT5-targeted therapy in mantle cell lymphoma;Blood Advances;2023-12-29

4. Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma;Annals of Translational Medicine;2022-12

5. Tackling Mantle Cell Lymphoma in Europe;Healthcare;2022-09-03